UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010336
Receipt number R000012100
Scientific Title Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC
Date of disclosure of the study information 2013/04/01
Last modified on 2018/04/17 14:48:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC

Acronym

Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC

Scientific Title

Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC

Scientific Title:Acronym

Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC

Region

Japan


Condition

Condition

Completely resected NSCLC(non-squamous cell carcinoma, stage II - IIIA)

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate feasibility of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLC (non-squamaous cell carcinoma) with staged II to IIIA.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Chemotherapy compliance in the four cycles

Key secondary outcomes

1.safety
2.extraction rate from hospitalization to outpatient clinic
3.2-years disease free survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Dose:day1 CDDP 75mg/m2+PEM 500 mg/m2 with short hydration
Cycle: 4 cycles

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)The patient histologically proven as non-small cell lung cancer
(2)The patient with p-staged II - IIIA that received segmentectomy, lobectomy, or bi-lobectomy
(3) Performance Status is 0 - 1 (ECOG).
(4) 20 years of age or older, 75 years of age or younger.
(5) The patient who does not receive any chemotherapy, radiotherapy, or immunotherapy prior to resection
(6) The patient who preserves the main organ ( the bone marrow, liver, kidney and so on )
(7) The patient who can receive chemotherapy within 4 - 8 weeks after resection
(8) The patient who gives written informed consent

Key exclusion criteria

(1)The patient with infection
(2)The patient with fever (equal to or more than 38 C)
(3)The patient with heavy complication
(4)The patient with active double-cancer
(5)The patient with uncontrolled pleural effuson
(6)The patient with a motor-palsy or figure of peripheral-nerve-disease
(7)The patient with drug hypersensitivity
(8)The patient with common use of NSAIDs
(9)The expectant mother, the woman who has a lactating-woman and the possibility of the pregnancy
(10)The patient judged as unsuitable by the doctor

Target sample size

21


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Motoko Tachihara

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine,

Zip code


Address

7-5-1, Kusunoki-Cho,Chuo-Ku, Kobe

TEL

078-382-5846

Email

mt0318@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Motoko Tachihara

Organization

Kobe University Graduate School of Medicine

Division name

Division of Respiratory Medicine, Department of Internal Medicine,

Zip code


Address

7-5-1, Kusunoki-Cho,Chuo-Ku, Kobe

TEL

078-382-5846

Homepage URL


Email

mt0318@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2013 Year 03 Month 13 Day

Date of IRB


Anticipated trial start date

2013 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 03 Month 28 Day

Last modified on

2018 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012100